Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

NCT02045030 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class

Stopped Drug (Aflibercept) no longuer available for the study

Conditions

Interventions

Sponsor

CR-CSSS Champlain-Charles-Le Moyne

Collaborators